{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T20:17:02Z","timestamp":1758053822894,"version":"3.44.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,14]]},"DOI":"10.7759\/cureus.92304","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:14:06Z","timestamp":1757895246000},"source":"Crossref","is-referenced-by-count":0,"title":["Health Disparities in Achieving Sustained Virologic Response Among Patients With Chronic Hepatitis C: A Retrospective Single-Center Study"],"prefix":"10.7759","author":[{"given":"Eileen","family":"Leach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricky","family":"Rana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Reinecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manasa","family":"Velagapudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Polaris dashboard - Global. (2025). Accessed. January 30, 2025: https:\/\/cdafound.org\/polaris\/dashboard\/."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.11.021","article-title":"Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity","volume":"74","author":"Krassenburg LA","year":"2021","unstructured":"Krassenburg LA, Maan R, Ramji A, et al.. Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity. J Hepatol. 2021, 74:1053-63. 10.1016\/j.jhep.2020.11.021","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003719","article-title":"Racial disparities in treatment rates for chronic hepatitis C: analysis of a population-based cohort of 73,665 patients in the United States","volume":"95","author":"Vutien P","year":"2016","unstructured":"Vutien P, Hoang J, Brooks L Jr, Nguyen NH, Nguyen MH. Racial disparities in treatment rates for chronic hepatitis C: analysis of a population-based cohort of 73,665 patients in the United States. Medicine (Baltimore). 2016, 95:e3719. 10.1097\/MD.0000000000003719","journal-title":"Medicine (Baltimore)"},{"key":"ref4","unstructured":"Global hepatitis report 2017. (2017). Accessed. January 30, 2025: https:\/\/www.who.int\/publications\/i\/item\/9789241565455."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5604\/01.3001.0010.2732","article-title":"Outcomes for cirrhotic patients with hepatitis C virus 1B treated with asunaprevir and daclatasvir combination","volume":"16","author":"Tamori A","year":"2017","unstructured":"Tamori A, Hai H, Uchida-Kobayashi S, et al.. Outcomes for cirrhotic patients with hepatitis C virus 1B treated with asunaprevir and daclatasvir combination. Ann Hepatol. 2017, 16:734-41. 10.5604\/01.3001.0010.2732","journal-title":"Ann Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad344","article-title":"Direct-acting antiviral therapy for treatment of acute and recent hepatitis C virus infection: a narrative review","volume":"77","author":"Martinello M","year":"2023","unstructured":"Martinello M, Naggie S, Rockstroh JK, Matthews GV. Direct-acting antiviral therapy for treatment of acute and recent hepatitis C virus infection: a narrative review. Clin Infect Dis. 2023, 77:S238-44. 10.1093\/cid\/ciad344","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1353\/hpu.2020.0090","article-title":"Favorable sustained virologic response rates using direct-acting antiviral therapies at a large safety-net hospital","volume":"31","author":"Bryant A","year":"2020","unstructured":"Bryant A, Kalra A, Truesdale A, Pyle L, Martinez-Camacho A. Favorable sustained virologic response rates using direct-acting antiviral therapies at a large safety-net hospital. J Health Care Poor Underserved. 2020, 31:1213-27. 10.1353\/hpu.2020.0090","journal-title":"J Health Care Poor Underserved"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14241","article-title":"Ethnic disparities in progression to advanced liver disease and overall survival in patients with chronic hepatitis C: impact of a sustained virological response","volume":"46","author":"Le AK","year":"2017","unstructured":"Le AK, Zhao C, Hoang JK, et al.. Ethnic disparities in progression to advanced liver disease and overall survival in patients with chronic hepatitis C: impact of a sustained virological response. Aliment Pharmacol Ther. 2017, 46:605-16. 10.1111\/apt.14241","journal-title":"Aliment Pharmacol Ther"},{"key":"ref9","unstructured":"U.S. Census Bureau Omaha City, Nebraska. (2023). Accessed. August 17, 2025: https:\/\/data.census.gov\/profile\/Omaha_city,_Nebraska?g=160XX00US3137000#health."},{"key":"ref10","article-title":"Resistance associated mutations in HCV patients failing DAA treatment","volume":"44","author":"Di Stefano M","year":"2021","unstructured":"Di Stefano M, Faleo G, Farhan Mohamed AM, et al.. Resistance associated mutations in HCV patients failing DAA treatment. New Microbiol. 2021, 44:12-8.","journal-title":"New Microbiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102596","article-title":"Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysis","volume":"72","author":"Levinsson A","year":"2024","unstructured":"Levinsson A, Zolopa C, Vakili F, et al.. Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysis. EClinicalMedicine. 2024, 72:102596. 10.1016\/j.eclinm.2024.102596","journal-title":"EClinicalMedicine"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-2803.201900000-79","article-title":"Sustained virologic response rate in chronic hepatitis C patients through direct-acting antivirals therapy","volume":"56","author":"Torres AD","year":"2019","unstructured":"Torres AD, Sparvoli JM, Sparvoli AC, Gon\u00e7alves CV.  Sustained virologic response rate in chronic hepatitis C patients through direct-acting antivirals therapy. Arq Gastroenterol. 2019, 56:394-8. 10.1590\/S0004-2803.201900000-79","journal-title":"Arq Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000001447","article-title":"Prevalence and characteristics of chronic hepatitis C among Asian Americans are distinct from other ethnic groups","volume":"55","author":"Tien A","year":"2021","unstructured":"Tien A, Sahota A, Yang SJ, Balbuena R, Chang M, Lim C, Fong TL. Prevalence and characteristics of chronic hepatitis C among Asian Americans are distinct from other ethnic groups. J Clin Gastroenterol. 2021, 55:884-90. 10.1097\/MCG.0000000000001447","journal-title":"J Clin Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12989","article-title":"Findings from a large Asian chronic hepatitis C real-life study","volume":"25","author":"Lim SG","year":"2018","unstructured":"Lim SG, Phyo WW, Shah SR, et al.. Findings from a large Asian chronic hepatitis C real-life study. J Viral Hepat. 2018, 25:1533-42. 10.1111\/jvh.12989","journal-title":"J Viral Hepat"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/381800-health-disparities-in-achieving-sustained-virologic-response-among-patients-with-chronic-hepatitis-c-a-retrospective-single-center-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:14:08Z","timestamp":1757895248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/381800-health-disparities-in-achieving-sustained-virologic-response-among-patients-with-chronic-hepatitis-c-a-retrospective-single-center-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,14]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.92304","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,14]]}}}